Zhibao Technology Explores $32M Digital Asset Injection for Reinsurance Arm

Key Facts

1Zhibao Technology's subsidiary Zhibao Labuan Re approved exploring a potential $32 million capital injection in digital assets.

2The proposed funding aims to strengthen reinsurance capacity and expand business operations across China and Southeast Asia.

In a move reflecting the growing integration of modern financial technologies into the traditional insurance sector, Zhibao Technology announced that its subsidiary, Zhibao Labuan Re, has approved exploring a potential $32 million capital injection. According to reports, the proposed funding is intended to be executed in the form of digital assets to bolster the subsidiary's capital base. This strategic step aims to strengthen reinsurance capacity and expand business operations across mainland China and Southeast Asian markets.

This initiative comes as InsurTech firms seek to optimize their financial positions to support regional growth, with Zhibao targeting enhanced risk-retention capabilities through this capital boost. Based on available data, utilizing digital assets for capital injection represents an ambitious strategy to provide the liquidity necessary for expansion within the reinsurance corridors connecting China and neighboring Asian economies.

Regarding stock performance, ZBAO shares stood at $0.121 at the close of September 21, 2026, within a daily trading range of $0.1078 to $0.1348. Traders are currently monitoring the company's ability to convert this exploration into a finalized capital flow, considering the volatility of digital assets, while the immediate economic calendar shows no direct catalysts following the Fed's decision to set interest rates at 4% on September 16.